MEMPHIS, Tenn.--(BUSINESS WIRE)--PMC Biogenix, Inc., a wholly owned subsidiary of PMC Group, as part of its continuing effort to strengthen and build upon customer relationships, has initiated a comprehensive review of its go to market strategy. As part of this process, PMC Biogenix is consolidating certain historical product distribution channels in order to more efficiently serve its customer base and align more closely with customers’ interests.
After initial review, PMC Biogenix has removed the following supplier partners from their approved direct sale list:
- Charles Tennant and Co. Canada Ltd.
- H. M. Royal, Inc.
- Lincoln Fine Ingredients, Inc.
- Mutchler Inc.
- Selectchemie AG
Customers currently purchasing PMC Biogenix, Inc. brand product - Armoslip®, Hystrene®, Industrene®, Kemamide®, and Kemester® - from any of these companies, are to contact PMC Distribution Specialist, Ms. Miriam Thompson at 901-325-4947 to assist in finding an authorized distributor and to avoid supply disruptions.
For more information on PMC Biogenix, Inc., please visit www.pmc-group.com.
PMC Group is a growth oriented, diversified, global chemicals and plastics company dedicated to innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation and marketing platform with facilities in the Americas, Europe and Asia. More information about PMC and its activities around the world can be found at www.pmc-group.com.